Abionyx Pharma ABNX Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Europe
EU
Abionyx Pharma (ABNX)
Abionyx Pharma (ABNX) Financials

Abionyx Pharma (ABNX)

1.266

-0.006

(-0.47%)

Closed November 26 10:30AM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Total Revenue	0	0	174k	0	0	678k	5.28M	4.74M
Operating Income	-24.04M	-6.64M	-6.34M	-2.53M	-2.97M	-5.95M	-3.99M	-3.41M
Pre Tax Income	-24.88M	-4.98M	-6.3M	1.89M	-1.89M	-5.82M	-4.21M	-3.52M
Net Income	-24.87M	-4.98M	-6.31M	1.85M	-1.89M	-5.82M	-4.21M	-3.52M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-1.362	-0.272	-0.333	0.084	-0.077	-0.209	-0.148	-0.108
EBIT	-24.04M	-6.64M	-7.05M	-2.53M	-2.97M	-5.95M	-4.11M	-3.41M
EBITDA	-23.98M	-6.59M	-6.3M	-2.24M	-2.89M	-5.83M	-3.48M	-2.89M

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions